Insider Transactions in Q1 2025 at Jazz Pharmaceuticals PLC (JAZZ)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Open market or private sale
|
Direct |
2,403
-2.93%
|
$331,614
$138.41 P/Share
|
|
Mar 10
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,140
-13.98%
|
$156,180
$137.81 P/Share
|
|
Mar 07
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,333
-14.05%
|
$183,954
$138.23 P/Share
|
|
Mar 07
2025
|
Mary Elizabeth Henderson SVP, Technical Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
698
-2.94%
|
$96,324
$138.23 P/Share
|
|
Mar 07
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Open market or private sale
|
Direct |
7,080
-4.03%
|
$984,120
$139.11 P/Share
|
|
Mar 05
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,905
-4.42%
|
$262,890
$138.95 P/Share
|
|
Mar 05
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,088
-7.92%
|
$564,144
$138.95 P/Share
|
|
Mar 05
2025
|
Philip L Johnson EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,149
-2.24%
|
$158,562
$138.95 P/Share
|
|
Mar 05
2025
|
Renee D Gala President & COO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,704
-6.03%
|
$787,152
$138.95 P/Share
|
|
Mar 05
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,239
-5.55%
|
$722,982
$138.95 P/Share
|
|
Mar 05
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,251
-4.79%
|
$3,070,638
$138.95 P/Share
|
|
Mar 03
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
6,500
-1.38%
|
$936,000
$144.25 P/Share
|
|
Feb 28
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
773
-7.54%
|
$110,539
$143.29 P/Share
|
|
Feb 27
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
26,577
+12.88%
|
-
|
|
Feb 27
2025
|
Mary Elizabeth Henderson SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
9,244
+17.62%
|
-
|
|
Feb 27
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,719
+18.02%
|
-
|
|
Feb 27
2025
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
34,666
+16.33%
|
-
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,889
+21.97%
|
-
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
868
-5.41%
|
$123,256
$142.43 P/Share
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
4,813
-19.5%
|
$693,072
$144.42 P/Share
|
|
Feb 27
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,813
+14.82%
|
$567,934
$118.23 P/Share
|
|
Feb 27
2025
|
Philip L Johnson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,111
+19.61%
|
-
|
|
Feb 27
2025
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,296
+15.76%
|
-
|
|
Feb 27
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,800
-10.24%
|
$547,200
$144.87 P/Share
|
|
Feb 27
2025
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,814
+6.15%
|
-
|
|
Feb 03
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.34%
|
$183,000
$122.31 P/Share
|
|
Jan 17
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,840
-3.04%
|
$1,688,480
$122.62 P/Share
|
|
Jan 17
2025
|
Bruce C Cozadd Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,559
+6.1%
|
-
|
|
Jan 17
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,181
-3.12%
|
$266,082
$122.62 P/Share
|
|
Jan 17
2025
|
Robert Iannone EVP, Global Head of R&D & CMO |
BUY
Grant, award, or other acquisition
|
Direct |
7,506
+9.69%
|
-
|
|
Jan 17
2025
|
Renee D Gala President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,300
-5.22%
|
$402,600
$122.62 P/Share
|
|
Jan 17
2025
|
Renee D Gala President & COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,741
+10.91%
|
-
|
|
Jan 17
2025
|
Patricia Carr SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,641
+16.61%
|
-
|
|
Jan 17
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,365
-5.1%
|
$166,530
$122.62 P/Share
|
|
Jan 17
2025
|
Samantha Pearce EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,533
+8.64%
|
-
|
|
Jan 17
2025
|
Neena M Patil EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,905
-4.88%
|
$232,410
$122.62 P/Share
|
|
Jan 17
2025
|
Neena M Patil EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,864
+13.06%
|
-
|
|
Jan 02
2025
|
Bruce C Cozadd Chairman & CEO |
SELL
Open market or private sale
|
Direct |
1,500
-0.35%
|
$184,500
$123.43 P/Share
|